Skip to main content

Table 1 Patient and tumour characteristics for trainning cohort

From: Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer

 

TFC (n = 15)

PCa (n = 15)

CRPC (n = 15)

Age (years)

   

 Median (range)

54 (50–75)

73.5 (52–87)

75 (66–82)

Baseline PSA (ng/ml)

   

 Median (range)

 

8.6 (0.004–167)

23.04 (0.36–100)

Local treatment, n (%)

   

 Endocrinotherapy

 

10 (67%)

11 (73%)